Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma

Published 2017 View Full Article

Authors

Keywords

Journal

MEDICINE

Volume 96, Issue 1, Pages e5787

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2017-01-11

DOI

10.1097/md.0000000000005787

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

MEDICINE

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Become a Peeref-certified reviewer